ArticleBioscience reports2020

Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases.

Guode Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.